| Dataset date: February 19, 2021-August 16, 2022
This dataset contains COVID-19 vaccine dose availability forecasts as well as actual deliveries for countries with Humanitarian Response Plans. The data on vaccine availability forecasts was manually extracted from the COVAX Facility Interim Distribution Forecast as announced by COVAX on 3 February 2021. Figures for actual deliveries through channels other than COVAX are compiled by OCHA from press reports. The source(s) press releases, official announcements or articles for each such vaccine delivery are included in the dataset.
| Dataset date: December 16, 2020-August 13, 2022
The map and chart below show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this does not measure the total number of people that have been vaccinated (which is usually two doses).
1 September 2021
| Dataset date: June 02, 2021-August 18, 2021
Subnational Covid19 vaccination data in Burkina Faso per region from the beginning of the vaccination campaign.
Vaccine type : AstraZeneca ; Johnson & Johnson
Details : first & second dose
Data : new vaccinated, cumulative vaccinated, new health workers vaccinated, cumulative health workers vaccinated
24 May 2021
| Dataset date: April 12, 2021-April 12, 2021
As a follow up to GeoPoll’s 2020 reports on the impact of COVID-19 in sub-Saharan Africa, GeoPoll conducted a survey to assess the ongoing effects of the pandemic on respondents’ finances, spending, and health, their thoughts and concerns about the vaccine, and their hopes for the future. The study was conducted by SMS in March 2021 in Côte D’Ivoire, the Democratic Republic of Congo (DRC), Kenya, Mozambique, Nigeria, and South Africa. Sample size of 400 per country, nationally representative by age, gender and location (ADM1). To request sub-national data contact email@example.com.
23 April 2021
| Dataset date: October 14, 2020-March 14, 2021
This data set includes vaccine-related rumour content from Internew's Rooted in Trust Project. The data set contains instances of COVID-19 related rumours shared on social media and in person with Internews in Afghanistan, Lebanon, Philippines, Colombia, Sudan, Mali, and CAR in 2020 and 2021.
11 March 2021
| Dataset date: February 03, 2021-February 03, 2021
This dataset contains a forecast on early availability of doses of the Pfizer-BioNTech vaccine and the AstraZeneca/Oxford vaccine to COVAX Facility participants. The forecast is as at 3 February 2021.
This dataset contains figures on indicative distribution of 240 million doses of the AstraZeneca/Oxford vaccine, licensed to Serum Institute of India (SII) and 96 million doses of the AstraZeneca/Oxford vaccine, under the advance purchase agreement between Gavi, the Vaccine Alliance and AstraZeneca for Q1 & Q2 2021. It also contains an overview of exceptional first round allocation of 1.2 million doses of the WHO Emergency Use Listing (EUL)-approved Pfizer-BioNTech vaccine for Q1 2021.
The data was manually extracted from the The COVAX Facility Interim Distribution Forecast which was announced by COVAX on 3 February 2021.
10 December 2020
| Dataset date: November 24, 2020-November 24, 2020
This study was conducted by SMS in late November in Côte D'Ivoire, DRC, Kenya, Mozambique, Nigeria, and South Africa. Topics covered include the ongoing impacts of COVID-19 on finances, physical and mental health, and spending on goods. Additionally, the study covers perceptions of vaccine safety and effectiveness and willingness to take a COVID-19 vaccine. Sample size of 500/country, nationally representative by age, gender, and location (ADM1). To request sub-national data please contact firstname.lastname@example.org